Balance Sheet
Cash Flow Statement
Gains from Investment Securities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Gains from Investment Securities (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Gains from Investment Securities for 4 consecutive years, with $212086.2 as the latest value for Q4 2022.

  • Quarterly Gains from Investment Securities fell 47.22% to $212086.2 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $212086.2 through Dec 2022, down 47.22% year-over-year, with the annual reading at -$16000.0 for FY2025, 245.45% down from the prior year.
  • Gains from Investment Securities for Q4 2022 was $212086.2 at NovaBridge Biosciences, down from $401818.9 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.4 million in Q4 2019, with the low at $212086.2 in Q4 2022.
  • Average Gains from Investment Securities over 4 years is $792088.6, with a median of $782004.5 recorded in 2020.
  • The sharpest move saw Gains from Investment Securities dropped 16.52% in 2020, then crashed 65.43% in 2021.
  • Over 4 years, Gains from Investment Securities stood at $1.4 million in 2019, then decreased by 16.52% to $1.2 million in 2020, then crashed by 65.43% to $401818.9 in 2021, then crashed by 47.22% to $212086.2 in 2022.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $212086.2, $401818.9, and $1.2 million for Q4 2022, Q4 2021, and Q4 2020 respectively.